Call toll-free 800.328.1267
Stocks just finished their best quarter in a generation, rebounding sharply from the coronavirus pandemic. The S&P 500 surged 20 percent between its close on March 31 and today. Technology, consumer stocks and energy led the rally as investors hunted for bargains...
Biotech stocks have been the poster child of relative strength in recent weeks. Relative strength (not to be confused with the Relative Strength Index) measures the performance of a stock or index against a broader benchmark like the S&P 500 index ($SPX.X). Though...
Sentiment has swung sharply bearish this week. President Trump's tariffs on China are a big part of the story, but health care's another major culprit. The biggest decliner in the S&P 500 today, for instance, was Mylan (MYL). Disappointing results, manufacturing...
There was a day when higher interest rates lifted financials. But not anymore. Selling in the sector has been intense, with 64 of the 67 members of the SPDR Financial ETF (XLF) down so far this week. Banks, insurers and asset managers have all taken a beating. (Don't...
Biotechnology stocks are trying to break out as investors await potential catalysts after Labor Day. The iShares Nasdaq Biotech ETF (IBB) has closed at new 52-week highs in the last two sessions. It's now pushing back to price areas last seen in the summer of 2015....
Tech stocks keep jumping as stocks nudge higher. Yesterday, we covered how names like Apple (AAPL) and Cisco Systems (CSCO) were sneaking to new highs. Today that trend continued as other prominent technology stocks also hit new records. First and foremost is...